Early Left Ventricular Diastolic Dysfunction in Females with Chronic Hyperprolactinemia: A Doppler Echocardiographic Study.
Michele ArcopintoRoberta D'AssanteRenata Simona AuriemmaRosa PirchioRosario PivonelloEduardo BossoneAnnamaria ColaoAntonio CittadiniPublished in: Journal of clinical medicine (2023)
Despite the myocardial prolactin (PRL) binding activity and the known effect of enhancing contractility in the isolated rat heart, little information is available concerning the cardiovascular consequences of hyperprolactinemia in humans. To elucidate the effects of chronic hyperprolactinemia on cardiac structure and function, twenty-four patients with isolated PRL-secreting adenoma and twenty-four controls underwent a complete mono- and two-dimensional Doppler-echocardiography. Blood pressure and heart rate were similar in the two groups, and no significant differences were observed as to left ventricular (LV) geometry between patients and controls. Resting LV systolic function was normal in patients with hyperprolactinemia, as shown by similar values of fractional shortening and cardiac output. Conversely, hyperprolactinemic patients exhibited a slight impairment of LV diastolic filling, as demonstrated by the prolongation of the isovolumetric relaxation time and the increase of the atrial filling wave of mitral Doppler velocimetry (58 ± 13 vs. 47 ± 8 cm/s, p < 0.05) with a subgroup of females (16%) having a clear diastolic dysfunction, and a worse exercise capacity (6 min walking test 452 ± 70 vs. 524 ± 56; p < 0.05). In conclusion, hyperprolactinemia in humans may be associated with a slight impairment of diastolic function, with an overt diastolic dysfunction in a subgroup of females which correlated with poorer exercise performance, in the absence of significant abnormalities of LV structure and systolic function.
Keyphrases
- left ventricular
- blood pressure
- heart rate
- left atrial
- hypertrophic cardiomyopathy
- heart failure
- cardiac resynchronization therapy
- mitral valve
- acute myocardial infarction
- aortic stenosis
- ejection fraction
- end stage renal disease
- newly diagnosed
- heart rate variability
- chronic kidney disease
- oxidative stress
- physical activity
- high intensity
- clinical trial
- healthcare
- type diabetes
- atrial fibrillation
- hypertensive patients
- transcatheter aortic valve replacement
- blood glucose
- patient reported
- patient reported outcomes
- adipose tissue
- metabolic syndrome
- resistance training
- pulmonary hypertension
- coronary artery disease
- lower limb
- single molecule
- social media